Triethylamine → Diethyl 3-tert.butyl-2-isoxazolin-5-ylphosphonate

HRID 1084800

Reaktionsgleichung

Reaktionsgleichung von HRID 1084800
[CH:1](=[N:6][OH:7])[C:2]([CH3:5])([CH3:4])[CH3:3].ClN1C(=O)CCC1=O.[CH:16]([P:18](=[O:25])([O:22][CH2:23][CH3:24])[O:19][CH2:20][CH3:21])=[CH2:17].C(N(CC)CC)C>ClCCl.N1C=CC=CC=1>[C:2]([C:1]1[CH2:17][CH:16]([P:18](=[O:25])([O:22][CH2:23][CH3:24])[O:19][CH2:20][CH3:21])[O:7][N:6]=1)([CH3:5])([CH3:4])[CH3:3]

Komponenten

7

Versuchsvorschrift

The procedure is analogous to that of Example 25 using 15.2 g (0.15 mol) of pivalaldoxime, 22.0 g (0.165 mol) of N-chlorosuccinimide, 0.5 ml of pyridine, 27.1 g (0.165 mol) of diethyl vinylphosphonate and 22.9 ml (0.165 mol) of triethylamine in dichloromethane. The product is obtained as an oil after the usual working up.

Aufarbeitung

  1. customThe product is obtained as an oil after the

Quellen und Nachweise

ORD-Eintrag
ord-f7ff29b72e2e4375b1d0bcfc664d7b01
Quelldatensatz
uspto-grants-1991_04
Patentnummer
US05006515

Verknüpfte Notizen

Wird geladen…